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Abstract. 
 
Collagen ﬁbrillogenesis is ﬁnely regulated
during development of tissue-speciﬁc extracellular ma-
trices. The role(s) of a leucine-rich repeat protein sub-
family in the regulation of ﬁbrillogenesis during tendon
development were deﬁned. Lumican-, ﬁbromodulin-,
and double-deﬁcient mice demonstrated disruptions in
ﬁbrillogenesis. With development, the amount of lumi-
can decreases to barely detectable levels while ﬁbro-
modulin increases signiﬁcantly, and these changing pat-
terns may regulate this process. Electron microscopic
analysis demonstrated structural abnormalities in the
ﬁbrils and alterations in the progression through differ-
ent assembly steps. In lumican-deﬁcient tendons, alter-
ations were observed early and the mature tendon was
nearly normal. Fibromodulin-deﬁcient tendons were
comparable with the lumican-null in early developmen-
tal periods and acquired a severe phenotype by matura-
tion. The double-deﬁcient mice had a phenotype that
was additive early and comparable with the ﬁbromodu-
lin-deﬁcient mice at maturation. Therefore, lumican
and ﬁbromodulin both inﬂuence initial assembly of in-
termediates and the entry into ﬁbril growth, while ﬁbro-
modulin facilitates the progression through growth
steps leading to mature ﬁbrils. The observed increased
ratio of ﬁbromodulin to lumican and a competition for
the same binding site could mediate these transitions.
These studies indicate that lumican and ﬁbromodulin
have different developmental stage and leucine-rich re-
peat protein speciﬁc functions in the regulation of ﬁbril-
logenesis.
Key words: collagen • proteoglycans • lumican • ﬁ-
bromodulin • tendon
 
Introduction
 
The tissue-specific assembly of extracellular matrix results
in distinct structural and functional properties. Collagen
fibril assembly and growth, major events defining overall
extracellular matrix assembly and function, are finely regu-
lated during connective tissue development. The collagen
fibrils are heteropolymeric structures that contain more
than one fibrillar collagen and macromolecules associated
with the fibril surface (Birk and Linsenmayer, 1994). Fibril-
associated molecules have been implicated in regulating
progression of fibril assembly through a series of steps lead-
ing to the structurally and mechanically mature fibril.
In tendon, the type I collagen-containing fibril, orga-
nized into fibers (fibril bundles), is the major element
responsible for structure stabilization and the mechanical
attributes of this tissue. The fibril contains collagen mole-
cules assembled into a quarter-staggered array, and this
striated fibril has a 67-nm periodicity. Developing tendons
have been used extensively for studies of collagen fibrillo-
genesis in vivo. Fibril development is a multi-step process
and, in the avian metatarsal tendons, specific developmen-
tal periods are associated with distinct steps in collagen
fibril assembly and growth (Birk et al., 1989, 1990, 1995,
1996, 1997; Kadler et al., 1996; Nurminskaya and Birk,
1996; Young et al., 2000). During the early period of devel-
opment, short, small-diameter fibril intermediates are
formed and the “molecular assembly” or “fibril assembly”
phase predominates. This is followed by fibril growth,
where fibrils become both longer and larger in diameter.
Interactions between the fibril-associated members of
the leucine-rich repeat family of proteoglycans and fibril-
lar collagen are obvious candidates for regulating the dif-
ferent tissue-specific steps in collagen fibrillogenesis. Fi-
bromodulin and lumican are members of a subfamily of
proteoglycans/glycoproteins with a leucine-rich repeat
structural domain (Iozzo, 1998, 1999). Fibromodulin is a
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keratan sulfate proteoglycan found in a variety of tissues
including tendon (Oldberg et al., 1989). Lumican is a ma-
jor keratan sulfate proteoglycan of the corneal stroma, but
is present in other collagenous extracellular matrices in a
glycoprotein form (Funderburgh et al., 1987). Decorin, a
chondroitin sulfate proteoglycan, is widely expressed, in-
cluding during tendon development (Birk et al., 1995).
These leucine-rich repeat proteins (LRR proteins)
 
1
 
 all
bind to fibrillar collagens (Vogel et al., 1984; Hedbom and
Heinegard, 1989; Rada et al., 1993). In vitro, it has been
shown that fibromodulin and lumican compete for the
same binding site (Svensson et al., 2000) and that this site
is separate from the decorin binding site (Hedbom and
Heinegard, 1993). In addition, fibromodulin, lumican, and
decorin all interact with striated fibrils (Scott, 1986; Prin-
gle and Dodd, 1990; Hedlund et al., 1994; Birk et al., 1995)
and can modulate collagen fibril formation and inhibit the
lateral growth of fibrils in vitro (Vogel et al., 1984; Hed-
bom and Heinegard, 1993; Rada et al., 1993). Also, the ab-
normal lateral growth of isolated fibrils was prevented by
this class of proteoglycans (Birk et al., 1996).
Gene-targeting studies of lumican, fibromodulin, and
decorin indicate that these leucine-rich repeat proteins are
involved in the determination of the mature collagen fibril
structural phenotype in vivo (Danielson et al., 1997;
Chakravarti et al., 1998; Svensson et al., 1999). The ab-
sence of lumican affected the mature fibril architecture of
connective tissues such as cornea and skin. Null mutations
in fibromodulin and decorin produced abnormal fibril
structures in tendons and skin. In addition, the decorin
and lumican animal models demonstrated reduced dermal
tensile strength associated with the mature fibril defects,
indicating important functions of these proteins in connec-
tive tissue maturation. However, the analysis of the fibro-
modulin-deficient mouse is complicated by the increased
deposition of lumican into the matrix, suggesting a coordi-
nate regulation of these closely related members of the
same subfamily. To define the roles of these two closely
related molecules in tissue- and development-specific ex-
tracellular matrix assembly, the onset of fibrillar abnor-
malities during development of the LRR protein–deficient
mice should be elucidated.
The purpose of the current study is to define the role(s)
of a subfamily of leucine-rich repeat proteins, lumican and
fibromodulin, in the regulation of specific steps in collagen
fibrillogenesis during tendon development. The use of lu-
mican-null, fibromodulin-null, and double-null mice allow
the dissection of the regulatory functions of these mole-
cules in the sequential, developmental steps in tendon col-
lagen fibril assembly and growth.
 
Materials and Methods
 
Animals
 
Lumican-null mice (lum tm1sc/lum tm1sc) and fibromodulin-null mice
generated by targeted gene disruption have been described (Chakravarti
et al., 1998; Svensson et al., 1999). Lumican-null and fibromodulin-null
double knockout mice were generated by breeding homozygous lumican-
null and fibromodulin-null mice. Mice were genotyped separately for lu-
 
mican and fibromodulin by PCR. CD-1 out-bred wild-type, and lumican-
null, fibromodulin-null, and lumican/fibromodulin-null mice in the same
genetic background were housed at Case Western Reserve University
and/or Thomas Jefferson University. Only male mice were included in all
experiments except for the 4- and 10-d postnatal time point where sex was
not determined.
 
Semiquantitative Reverse Transcription–PCR
 
Semiquantitative reverse transcription (RT)–PCR was performed using
standard methods. Flexor digitorum longus tendons were dissected from
wild-type mice (CD-1). Embryos at E18 (
 
n
 
 = 6) and postnatal mice from 2
(8), 4 (10), 6 (8), 8 (9), 10 (10), 12 (11), 14 (7), 16 (7), and 21 d (3), and 4
(8), 8 (7), and 12 wk (8) were used. Each tendon was collected separately
and stored at 
 
2
 
80
 
8
 
C. Total RNA was isolated using Trizol reagent
(GIBCO BRL). The quantity and quality of isolated total RNA was de-
termined using spectrophotometry and electrophoresis. The RNA yield
was 1.5–6 
 
m
 
g per sample in stages before P14 and 6–20 
 
m
 
g in later stages.
To generate cDNA, 500 ng of total RNA was reverse transcribed in a 20-
 
m
 
l reaction using oligo-dT primer and M-MLV reverse transcriptase
(GIBCO BRL). Each LRR protein and glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH) were amplified simultaneously in the same tube
using 0.05 U/
 
m
 
l of Taq DNA polymerase in PCR buffer containing 1.5
mM MgCl
 
2
 
. Each primer was present at 0.2 
 
m
 
M with each dNTP at 200
 
m
 
M. The PCR program was optimized by adjusting annealing temperature
(60
 
8
 
C) and cycle numbers (25 cycles for fibromodulin, 24 cycles for lumi-
can). PCR products were electrophoresed in ethidium bromide–stained
agarose gels and analyzed densitometrically using a Gel Doc 2000 (Bio-
Rad Laboratories) and Quantity One software. The figures were prepared
using Adobe Photoshop. The experiments were repeated at least three
times with different batches of RNA. The following primer sets were used
for PCR: M-Fbm-635F (22 mer) 5
 
9
 
-TGGAGGGCCTGGAGAACCTCAC-
3
 
9
 
, M-Fbm-1052R (23 mer) 5
 
9
 
-GTGCAGAAGCTGCTGATGGAGAA-
3
 
9
 
, M-Lum-352F (23 mer) 5
 
9
 
-GTCACAGACCTGCAGTGGCTCAT-3
 
9
 
,
M-Lum-1004R (24 mer) 5
 
9
 
-ATCTTGGAGTAAGACAGTGGTCC-3
 
9
 
,
M-GAPDH-266F (22 mer) 5
 
9
 
-ATCTTCCAGGAGCGAGACCCCA-3
 
9
 
, and
M-GAPDH-555R (24 mer) 5
 
9
 
-TCCACAATGCCAAAGTTGTCATGG-3
 
9
 
.
 
Western Analysis
 
Flexor tendons were dissected from the hind limbs of 6–10 mice at 4 and
10 d postnatal and five or six mice at 1 mo postnatal. This was repeated for
three independent samples. The tendons were extracted in a fourfold ex-
cess (weight/volume) of 4 M guanidine-HCl, 50 mM sodium acetate, pH
5.8, with Complete™ protease inhibitors (Roche Molecular Biochemi-
cals). Protein extracts from tendons were prepared (Larsson et al., 1991)
and analyzed by protein transfer blots as described (Svensson et al., 1999).
 
Immunofluorescence Microscopy
 
Tendons from 4- and 10-d postnatal mice were fixed with 4% paraformal-
dehyde in PBS (pH 7.3) for 30 min on ice. The tissues were cryoprotected
with 2 M sucrose-PBS, and frozen in OCT (Tissue Tek; Miles Laborato-
ries). Sections (6 
 
m
 
m) were cut and picked up onto poly-
 
L
 
-lysine–coated
slides. Sections were treated with sodium borohydride (50 mg/100 ml
PBS) for 15 min at room temperature and nonspecific binding sites were
blocked by incubation in 5% BSA in phosphate buffered saline overnight
at 4
 
8
 
C (Young et al., 2000). Sections were then incubated in rabbit anti–
mouse lumican [1:250] or fibromodulin [1:250] prepared against recombi-
nant core proteins (Svensson et al., 1999). This was followed by secondary
goat anti–rabbit dichlorotriazynyl amino fluorescein–conjugated antibody
[1:150] (Jackson ImmunoResearch Laboratories). Negative controls were
incubated identically except the primary antibody was absent. The slides
were mounted in Vectashield™ (Vector Laboratories Inc.) and images
were captured using an Optronics digital camera. The final figures were
prepared using Adobe Photoshop.
 
Transmission Electron Microscopy
 
Mice were killed at 4 d, 10 d, 1 mo, and 3 mo after birth. Between three
and six mice were used for each of the 16 groups. The exact numbers for
each group are indicated in Fig. 6 (below). Hind limbs were fixed in situ in
4% paraformaldehyde, 2.5% glutaraldehyde, 0.1 M sodium cacodylate,
pH 7.4, with 8.0 mM CaCl
 
2
 
 for 15 min at room temperature, during which
time the flexor digitorium tendons were dissected. This was followed by
100 min at 4
 
8
 
C and processing as previously described (Birk and Trelstad,
1986; Birk et al., 1997). In brief, the tendons were post-fixed with 1% os-
 
1
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mium tetroxide and enbloc stained with 2% uranyl acetate/50% ethanol.
After dehydration in an ethanol series followed by propylene oxide, the
tendons were infiltrated and embedded in a mixture of Polybed 812, nadic
methyl anhydride, dodecenylsuccinic anhydride, and DMP-30 (Poly-
sciences, Inc.). Thick sections (1 
 
m
 
m) were cut and stained with methylene
blue–azur blue for examination and selection of specific regions for EM
analysis. Thin sections were prepared using a Reichert UCT ultramicro-
tome and a diamond knife. Staining was with 2% aqueous uranyl acetate
followed by 1% phosphotungstic acid, pH 3.2. Cross sections of midplan-
tar regions of flexor digitorum tendons were analyzed in fibromodulin-,
lumican-, fibromodulin/lumican-deficient and wild-type mice using elec-
tron microscopy. Sections were examined and photographed at 75 kV us-
ing a transmission electron microscope (Hitachi 7000).
 
Fibril Diameter Analyses
 
For each group, three to five different animals were analyzed. Micro-
graphs (11–34/group) from nonoverlapping regions of the central portion
of midplantar flexor digitorum tendons were taken from cross sections at
31,680
 
3
 
. For the purpose of statistical analysis, data from a single photo-
graphic negative, containing 100–300 diameter measurements was re-
garded as a sample and reduced to three sample statistics: first quartile,
median, and third quartile. We assumed that different samples were in-
dependent. The microscope was calibrated using a line grating. Micro-
graphs were randomly chosen in a masked manner from the different
groups, digitized, and diameters were measured using a Bioquant image
analysis system (RM Biometrics). Statistical analysis was performed to
compare the distributions of fibril diameters in the wild-type group and
each of the three deficient groups (lumican 
 
2
 
/
 
2
 
, fibromodulin 
 
2
 
/
 
2
 
, and
double lumican/fibromodulin 
 
2
 
/
 
2
 
) at 4 d and 3 mo postnatal. Since the
normality assumption was not generally supported by the data, only ex-
act nonparametric methods were employed in this analysis. Left-skewed
and sometimes bimodal distributions observed for the 3-mo time points
prohibited modeling the variance structure in the samples using a regular
mixed model. Therefore, for each of the samples, three statistics, sample
median, sample median-to-first quartile distance, and sample median-to-
third quartile distance, were analyzed. The median indicates the location
of the center of the distribution, while median-to-quartile distances re-
flect primarily the spread of the data and, secondarily, in the case of non-
symmetric distribution, the degree of skewness and possible bimodality.
Distributions of the sample to sample medians and both median-to-quar-
tile distances for each deficient group were compared with the wild-type
group using the Kolmogorov-Smirnov test. The null hypothesis of this
test was that there is no difference between the two compared distribu-
tions. To obtain 
 
P
 
 values, we used the Bonferoni adjustment (for three
multiple comparisons). Computations were done using the StatXact 4
(Cytel Software Co.) and SAS 6.12.
 
Results
 
Collagen fibrillogenesis is a multi-step process and, in the
avian metatarsal tendons, specific developmental periods
are associated with distinct steps in collagen fibril assem-
bly and growth (Birk et al., 1989, 1990, 1995, 1996, 1997;
Nurminskaya and Birk, 1996; Young et al., 2000). Here,
we defined analogous periods of development for the
mouse flexor tendons and analyzed temporal expression
of lumican and fibromodulin at these stages of tendon
development. Lumican-null, fibromodulin-null, and dou-
ble-null mice were used to determine how tendon fibril
formation and growth were affected in the absence of
these proteoglycans.
 
Normal Development of Collagen Fibrils in
Mouse Tendons
 
Fibrils were analyzed in cross sections of tendons from 2 d
to 7.5 mo in wild-type mice. Relative to specific stages in
chicken tendon development, electron microscopic analy-
sis of mouse tendons identified 4 d, 10 d, 1 mo, and 3 mo as
representative of different steps in fibrillogenesis (Fig. 1).
In the early postnatal period, characterized by the 4-d ten-
don, the collagen fibrils all had relatively small diameters
(64 
 
6
 
 12 nm, mean 
 
6 
 
SD). By 10-d postnatal, the fibril di-
ameters were heterogeneous, with larger diameter fibrils
present, in addition to smaller diameter fibrils characteris-
tic of 4 d. By 1 mo, there was a broad distribution of fibril
diameters with large diameter fibrils being characteristic
of this stage. From 1 to 3 mo, the fibril diameters changed
only modestly with the largest diameter fibrils being more
prominent in the oldest tendons. The specific stages de-
scribed were defined as representative of the initial assem-
Figure 1. Collagen fibril structure dur-
ing development in wild-type mouse
tendons. Transmission electron micro-
graphs of transverse sections from
mouse flexor tendons from normal
mice (a–d). Fibril structure was ana-
lyzed at different developmental
stages, 4 d (a), 10 d (b), 1 mo (c), and 3
mo (d) postnatal. Bar, 300 nm.
Figure 2. Expression of lumican and fibromodulin during normal
tendon development. Lumican and fibromodulin expression
were analyzed using semiquantitative RT-PCR. (a) Representa-
tive ethidium bromide stained gels showing PCR product bands
for lumican, fibromodulin, and coamplified GAPDH bands.
Three or four different batches of PCR products generated from
independently prepared total RNA between postnatal day 4 and
16 or day 21 and 3 mo were applied to a single gel. (b and c) Band
density was determined densitometrically and relative density
was obtained by using both band density and the PCR product
size ratio, lumican 656 bp, fibromodulin 418 bp, and GAPDH 289
bp. The relative density was normalized using GAPDH and plot-
ted for (b) lumican and (c) fibromodulin. 
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bly of immature fibril intermediates (4 d), the transition
from fibril assembly to growth (10 d), and fibril growth to
maturation (1–3 mo). The 3-mo tendon is characteristic of
a mature tendon that has completed growth.
 
Temporal Expression Patterns of Leucine-rich
Repeat Proteoglycans
 
The leucine-rich repeat proteins have been implicated in
regulating fibrillogenesis, and we propose that they are in-
volved in regulating the multiple steps observed in tendon
fibril formation. Therefore, the temporal expression pat-
terns of lumican and fibromodulin were analyzed during
tendon development. Semiquantitative RT-PCR was used
to analyze expression patterns for multiple independent
samples from 2-d postnatal to adult (Fig. 2). Analysis dem-
onstrated that each proteoglycan had peak expression dur-
ing early stages from 2 to 14 d. Lumican expression peaked
earliest at 
 
z
 
8 d, and then decreased dramatically. Fibro-
modulin expression peaked at 14 d and decreased slightly
to 1-mo postnatal, followed by a dramatic decrease in the
adult expression levels.
The amount of lumican and fibromodulin core protein
present during normal development was analyzed using
semiquantitative Western analysis. Fibromodulin core
protein increased by 
 
z
 
30–40% from 4 d to 1 mo, while lu-
mican decreased by 
 
z
 
60–70% during the same period
(Fig. 3). The spatial distribution of the core proteins was
analyzed by immunofluorescence histochemistry during
normal tendon development. Reactivity for lumican and
fibromodulin was present throughout the tendon matrix at
10-d postnatal (Fig. 4). Comparable results were observed
in the 4-d and 1-mo tendon (data not shown); however, lu-
mican reactivity was decreased in the 1-mo matrix, consis-
tent with the core protein content. This localization to the
region of tendon fibril formation rather than a spatially re-
stricted pattern, for example to the tendon sheath, demon-
strates that regulatory interactions are possible. The con-
trols without primary antibody or with an irrelevant
antibody were negative. Taken together, these data sug-
gest that lumican functions during early stages in fibrillo-
genesis, while fibromodulin would function throughout
this period with a more prominent role in regulation of the
later stages. The codistribution of lumican and fibromodu-
lin with collagen fibrils is consistent with the regulation of
fibrillogenesis.
 
Collagen Fibril Structure during Development in 
Lumican-, Fibromodulin- and Double
Lumican/Fibromodulin–deficient Mice
 
The formation of collagen fibrils during tendon develop-
ment in mice deficient in lumican, fibromodulin, or both
was analyzed. The fibrils from lumican-, fibromodulin-, and
double lumican/fibromodulin–deficient mice showed ab-
normalities during development relative to the wild-type
controls (Fig. 5). Structurally, three distinct abnormalities
were observed. First was the premature presence of fibril di-
ameter heterogeneity in the 4-d double-deficient tendon
relative to the wild-type controls (Fig. 5, a and m). Sec-
ondly, there was an abnormally large number of small diam-
eter fibrils present in the later stages of development, best
seen at 3 mo, in the fibromodulin- and double-deficient
mice (Fig. 5, l and p). Finally, all three deficient conditions
had fibrils with irregular profiles, indicative of abnormal lat-
eral association or a defect in molecular rearrangement af-
ter fusion. The 1–3-mo fibromodulin- and double-deficient
tendons had large numbers of very abnormal “cauliflower”
fibrils, with the double-deficient tendons showing the most
severe phenotype (Fig. 5, k, l, o, and p). In contrast, the lu-
mican-deficient tendons contained fibrils only slightly irreg-
ular in profile at 1–3 mo (Fig. 5, g and h).
Figure 3. Lumican and fibromodulin content during normal ten-
don development. (a) A representative semiquantitative Western
analysis of lumican and fibromodulin during development in the
normal mouse tendon is presented. Tendons were extracted in
4 M guanidine-HCl at 4 d, 10 d, and 1 mo. 80, 40, and 20 mg of to-
tal protein from each time point were loaded onto the gel. The
core proteins were transferred, reacted with antilumican or anti-
fibromodulin antisera followed by radiolabeled goat anti–rabbit
IgG, and quantitated using phosphoimaging. A duplicate gel
stained with Coomassie shows similar amounts of type I collagen
in the extracts. (b) The relative lumican and fibromodulin con-
tent in the tendon at 4 d, 10 d, and 1 mo postnatal were derived
from three independent experiments. The mean values for both
lumican and fibromodulin were set to 100 at 4 d and the results
were plotted as a function of development (bars indicate SD).
Figure 4. Localization of lumican and fibromodulin core proteins
in normal tendon development. Immunofluorescence microscopy
showing the localization of lumican (a) and fibromodulin (b) core
proteins in longitudinal sections of normal mouse tendons at 10 d
postnatal. Control sections (c) were treated identically without
the primary antibody. Bar, 50 mm. 
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Collagen Fibril Diameter Distributions during 
Development of Lumican-Null, Fibromodulin-Null, 
and Double Lumican/Fibromodulin-Null Tendons
 
The structural analysis of tendon fibrils (Fig. 5) indicated
that alterations in lumican and fibromodulin expression
disrupted the regulation of fibrillogenesis, leading to alter-
ations in fibril structure. To assess the function of these
proteoglycans, we analyzed the fibril diameters quantita-
tively during development in the mutant mice.
To characterize the diameter distributions, all the fibril
diameters measured (
 
n
 
 = 1904–5909) were plotted in sin-
gle histogram for each group at each developmental point
(Fig. 6). To make statistical comparisons possible, the di-
ameter distribution from each photographic negative was
separately treated as single sample, and parameters defin-
ing the diameter distributions were compared for each de-
ficient group with the wild-type group (Table I). The me-
dian was used to indicate the center of the distribution,
while median-to-quartile distances reflect the spread of
Figure 5. Collagen fibril structure during development in normal wild-type, lumican-, fibromodulin-, and double lumican/fibromodu-
lin–deficient mice. Transmission electron micrographs of transverse sections from mouse flexor tendons from normal mice (a–d) and
mutant mice (e–p). Fibril structure was analyzed at different developmental stages between 4 d and 3 mo postnatal, 4 d (a, e, i, and m),
10 d (b, f, j, and n), 1 mo (c, g, k, and o), and 3 mo (d, h, l, and p) postnatal. Arrows indicate fibrils with diameters of z64 nm, the diam-
eter seen in normal 4-d postnatal tendons. Arrowheads indicate irregular fibril profiles. Bar, 300 nm. 
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the data and, secondarily, in the case of nonsymmetric dis-
tribution, the degree of skewness and possible bimodality.
At 4-d postnatal, the lumican- and fibromodulin-defi-
cient tendons had fibril diameter distributions that were
similar to that observed from wild-type tendon with a
mean diameter of 64 nm (Fig. 6, a, e, and i). However, the
diameter distributions for lumican- and fibromodulin-defi-
cient mice were shifted to larger diameters; i.e., 72 and 71
nm, respectively. The double-deficient tendons had a
broader diameter distribution and there was a shift to even
larger diameter fibrils; i.e., 87 nm (Fig. 6 m). Significant
differences between the wild-type distribution and the dif-
ferent deficient distributions were shown using a Kolmog-
orov-Smirnov test (Table I). This demonstrated that the
effect of the single mutations was additive during this pe-
riod of fibrillogenesis and that this class of leucine-rich re-
 
peat proteins influenced the assembly of immature fibril
intermediates.
At 10-d postnatal, both the lumican- and fibromodulin-
deficient tendons had a decrease in the number of the larg-
est diameter fibrils, with a peak at 
 
z
 
130 nm, compared
with the normal tendon. The fibrils with diameters 
 
,
 
65 nm
were similar to the wild-type tendon. Both deficient ten-
dons demonstrated an accumulation of fibrils with inter-
mediate diameters relative to the wild-type tendon (Fig. 6,
f and j). The lumican-deficient tendons had relatively equal
numbers of fibrils in all intervals between 65 and 140 nm,
while the fibromodulin-deficient tendon demonstrated a
clustering at the small diameter end of this range. In spite
of the structurally abnormal, irregular fibril profiles (Fig.
5 n), the double lumican/fibromodulin-deficient tendon
fibrils had a relatively normal distribution with no appar-
Figure 6. Collagen fibril diameter distributions during development of wild-type, lumican-null, fibromodulin-null, and double lumican/
fibromodulin–null tendons. Collagen fibril diameter distributions are presented as histograms for wild-type (a–d), lumican-deficient
(e–h), fibromodulin-deficient (i–l), and double lumican/fibromodulin–deficient (m–p) mouse tendons. Vertical dotted lines indicate
peaks observed in wild-type mouse tendons at z65, 120, 240, and 280 nm. (a–d) Means, SD, and number of fibrils measured (n)/number
of different animals (na) are presented as mean 6 SD (n/na) in the graphs.
 
Table I. Analysis of Fibril Diameter Distributions
 
Median Median-Q1 Median-Q3
No. Means 
 
6
 
 SD
 
P*
 
Means 
 
6
 
 SD
 
P*
 
Means 
 
6
 
 SD
 
P*
 
4 d
Wild type 11 65.0 
 
6
 
 4.5 — 7.9 
 
6
 
 1.6 — 7.5 
 
6
 
 1.4 —
Lumican deficient 21 74.1 
 
6
 
 7.6 0.005 10.1 
 
6
 
 2.1 0.037 8.3 
 
6
 
 1.7 NS
Fibromodulin deficient 12 72.1 
 
6
 
 6.7 0.019 12.0 
 
6
 
 3.5 0.012 10.8 
 
6
 
 3.2 0.047
Double deficient 15 88.5 
 
6
 
 9.4
 
,
 
0.001 20.6 
 
6
 
 6.1
 
,
 
0.001 18.5 
 
6
 
 5.2
 
,
 
0.001
3 mo
Wild type 34 241.0 
 
6
 
 35.9 — 61.0 
 
6
 
 18.9 — 47.1 
 
6
 
 10.3 —
Lumican deficient 21 250.0 
 
6
 
 34.6 NS 75.9 
 
6
 
 31.3 NS 46.9 
 
6
 
 12.8 NS
Fibromodulin deficient 20 181.0 
 
6
 
 32.8
 
,
 
0.001 79.0 
 
6
 
 22.3
 
,
 
0.001 71.4 
 
6
 
 28.4 0.001
Double deficient 15 138.0 
 
6
 
 26.4
 
,
 
0.001 63.7 
 
6
 
 18.2 NS 74.2 
 
6
 
 25.4
 
,
 
0.001
 
To define differences in fibril diameter distributions, the sample medians, sample median-to-first quartile (Q1) distance, and sample median-to-third quartile (Q3) distance were
analyzed. The values are presented as means 
 
6 
 
SD of the individual samples in each group. The median indicates the location of the center of the distribution, while median-to-quartile
distances reflect primarily the spread of the data and secondarily, in the case of nonsymmetric distribution, the degree of skewness and possible bimodality. Values are in nanometers. 
*
 
P
 
, Kolmogorov-Smirnov tests. The difference between the distribution of the wild-type values and corresponding deficient values were tested. 
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ent preference for different diameter ranges (Fig. 6 n).
This distribution is considered to be a transition from the
abnormal early phenotype to the later severe phenotype.
At 1–3-mo postnatal, the lumican-deficient tendon had a
fibril diameter distribution comparable with the wild-type
tendon (Fig. 6, c and d vs. g and h). In contrast, the fibromod-
ulin- and double-deficient tendon fibrils had diameter distri-
butions distinctly different from the normal tendon where
preferred fibril diameters were evidenced by a multimodal
peak (Fig. 6, k, l, o, and p). At 3 mo, these mutant tendons
demonstrated a substantial increase in the number of small
diameter fibrils; i.e., 65 nm. The double- and fibromodulin-
deficient distributions were quite similar. Significant differ-
ences between the distribution of fibril diameter in wild-type
tendons and both the fibromodulin- and double lumican/fi-
bromodulin-deficient groups were indicated by statistical
analysis (Table I). Fibromodulin expression appeared to be
required for the progression through fibril growth associated
with the later stages of tendon development.
This analysis indicated that, at postnatal day 4, the dis-
tribution of fibril diameters in the wild-type tendons was
significantly different from the distribution of fibril diame-
ters in each of the three deficient tendons. After 3 mo of
development, the distribution of fibril diameters in the
wild-type tendon was significantly different from the dis-
tribution of fibril diameters in the fibromodulin- and dou-
ble lumican/fibromodulin-deficient tendons. No significant
difference between the wild-type and lumican-deficient
tendons after 3 mo was found (Table I).
 
Discussion
 
Collagen fibrillogenesis during normal tendon develop-
ment involves multiple steps. First, a population of short,
small-diameter fibril intermediates are assembled. The reg-
ulation of the molecular assembly of immature fibril inter-
mediates involves the interaction of type-I collagen with a
quantitatively minor fibrillar collagen, such as type-III col-
lagen (Birk and Linsenmayer, 1994; Liu et al., 1997). In the
tendon, collagen type I/III interactions have been impli-
cated in the regulation of intermediate assembly during this
early developmental period (Fleischmajer et al., 1990; Birk
and Mayne, 1997). We have proposed that this intermedi-
ate is stabilized by interactions with fibril-associated mole-
cules. These interactions would have temporal changes
during development that would stabilize and destabilize the
fibril intermediate. This would regulate the progression
through the fibril growth steps and results in the mature,
tissue-specific fibril. In this work, we demonstrate that a
subfamily of the leucine-rich repeat proteins/proteoglycans
(i.e., lumican and fibromodulin) are important regulators
of the multiple steps in tendon fibrillogenesis.
 
Fibril Phenotypes Observed in Mutant Mouse Tendons 
Indicate Different Functions for Lumican
and Fibromodulin
 
An ultrastructural analysis of fibrils from different devel-
opmental periods in lumican-, fibromodulin-, and double
lumican/fibromodulin-deficient tendons demonstrated that
alterations in amounts of lumican and fibromodulin re-
sulted in abnormal fibril phenotypes. We classified these
into the following four types: (a) irregular fibril profiles,
(b) increased diameters of fibril intermediates observed at
4 d postnatal, (c) abnormally large number of small-diam-
eter (64-nm) fibrils in later stages of development, and (d)
a shift in the diameter distributions to smaller-diameter
fibrils relative to wild-type tendon, to a differing extent, in
all deficient mouse tendons.
An obvious structural phenotype is the formation of
fibrils with irregular fibril profiles that contrast strongly
with the normal circular profiles seen in wild-type tendons.
The structural defects were expected based on previous
work in mature tissues (Chakravarti et al., 1998, 2000;
Svensson et al., 1999). However, the temporal specificity
in appearance of these irregular fibrils could not have
been predicted, nor could the effect of lumican versus fi-
bromodulin deficiency. In the current study, this specific
fibril phenotype was shown to be present to varying de-
grees in all three mutant tendons by 3 mo with the lumi-
can-null phenotype very mild, the double-null phenotype
very severe, and the fibromodulin-null phenotype inter-
mediate in severity at this stage of development. Irregular
fibril contours were observed at different developmental
stages depending on the mutation; i.e., at 10 d to 3 mo with
progressing severity in the double-deficient mice, at 1 and
3 mo with mild severity in the lumican-null mice and at 1–3
mo with intermediate severity in the fibromodulin-null
mice. Even more novel than the developmental pattern in
abnormality of fibril contours were the leucine-rich repeat
protein–specific alterations in assembly and progression
through fibril growth steps reported here.
A second structural phenotype was the larger diameter
fibrils assembled in all the mutant mice during early devel-
opment. At 4 d of development, there was a shift in the
relatively homogeneous fibril diameter distributions to
larger diameters. There was a significant increase in mean
diameter of the small diameter population (i.e., 
 
2
 
64 nm
population from wild-type tendons) without abnormal
fibril profiles. We regard these fibrils (i.e., 64 nm), ob-
served in the wild-type tendons, as the initial fibril inter-
mediate originally called fibril segments (Birk et al., 1989).
The increased diameter indicates an alteration in initial in-
termediate assembly. The interaction between lumican
and/or fibromodulin and collagen fibrils could stabilize the
intermediate blocking accretion of collagen to the fibril.
There also is evidence that the LRR proteins can interact
with collagen molecules before fibril assembly (Scott et al.,
1990; Weber et al., 1996; Keene et al., 2000). An interac-
tion at this level could directly influence molecular assem-
bly and alter fibril diameter. Associated with this pheno-
type was the premature generation of a heterogeneous
population in the double-deficient tendons at 4 d postna-
tal. We interpret this as an additive effect on assembly due
to both lumican and fibromodulin deficiency. An alterna-
tive explanation is that there is an alteration in initial as-
sembly with a premature entry into the growth phase. The
lack of both lumican and fibromodulin would generate in-
termediates that prematurely enter the growth phase in
the absence of the normal regulatory block.
The third structural phenotype was the presence of an
abnormally large number of small diameter fibrils (64 nm
population) in the later stages of development in the fibro-
modulin- and double-deficient mice. This was observed
beginning at 10 d, but is obvious at 3 mo. This, coupled 
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with the relative lack of the large diameter fibrils in both
the fibromodulin-null and double-null mutant mice at 3
mo, indicates a defect in progression into and through the
fibril growth phase.
A fourth phenotype was the shift of the upper end of the
diameter distribution toward smaller fibrils. At 10 d, the
higher ratio of smaller to larger diameter fibrils was seen in
all deficient phenotypes. In the lumican-deficient tendon at
1–3 mo, the distribution became comparable with the wild-
type tendons. This indicated that the defect in the early
steps, due to loss of regulation by lumican, could be over-
come by a normal regulation that is fibromodulin dependent
in the later stages. At 1–3 mo, the alteration in diameter
distribution seen in the fibromodulin- and double-deficient
mice (i.e., decrease in numbers of largest diameter fibrils)
suggests that fibromodulin facilitates the growth to mature
fibrils. This phenotype was associated with a relative in-
crease in the numbers of fibrils found in the midrange of
the diameter distribution. This was consistent with the de-
fect being one of progression through intermediates in ad-
dition to entry into the growth phase. At this stage, the
double-deficient fibril diameter distribution most likely re-
flects the effects of fibromodulin since, at this time in nor-
mal development, lumican expression is low relative to fi-
bromodulin. The lack of preference for large diameter
fibrils in the fibromodulin and double-deficient tendon sug-
gests a loss of regulation of the transition through the later
growth stages during the formation of mature fibrils.
 
Multi-Step Model for Regulation of Fibrillogenesis by 
Lumican and Fibromodulin
 
Our model of fibril growth in the tendon and its regulation
by lumican and fibromodulin is presented in Fig. 7. The
first step in fibrillogenesis is the molecular assembly of col-
lagen monomers into fibril intermediates. Previous studies
have shown that growth at this stage is by accretion of col-
lagen and occurs within extracellular compartments,
where the microenvironment is under cellular control
(Birk and Trelstad, 1986). This initial assembly step is reg-
ulated, at least in part, by interactions between two fibril-
lar collagens. In the tendon, these are types I and III
(Fleischmajer et al., 1990; Birk and Mayne, 1997). In addi-
tion, our data indicate that both lumican and fibromodulin
influence this step, as evidenced by the larger diameter
fibrils seen at 4 d. Recent work indicates that decorin, a re-
lated leucine-rich repeat protein, may influence molecular
interactions at these early stages or perhaps within secre-
tory vesicles (Weber et al., 1996; Keene et al., 2000). These
fibrils have regular profiles that are inconsistent with pre-
mature entry into growth, although a rapid molecular rear-
rangement of the immature fibril intermediates cannot be
ruled out. Fibril intermediates 
 
z
 
64 nm in mouse tendons
are stabilized presumably through their interactions with
leucine-rich repeat proteoglycans. Our data indicate that
both lumican and fibromodulin are involved in this stabili-
zation and mediating the entry into fibril growth. The fibril
intermediates are the basic units used in the growth of
fibrils (Birk et al., 1989, 1995, 1997; Graham et al., 2000).
Fusion of the fibril intermediates generates the mature
fibril in a multi-step manner. Progression through this
growth process could be both by additive-fusion (i.e., the
64-nm diameter intermediate adds to its product) and by
like-fusion (i.e., products from different steps can only
fuse with like products of existing fibrils). We suggest that
changing patterns of lumican and fibromodulin expression
during tendon development are responsible for the regula-
tion of this process. As fibrillogenesis progresses, lumican
decreases to barely detectable levels while fibromodulin
Figure 7. Model for regulation of fibril growth by lumican
and fibromodulin. The steps in collagen fibrillogenesis dur-
ing tendon development are presented (a–c). (a) In the
early steps of fibril formation, the molecular assembly of
collagen monomers into fibril intermediates occurs in the
pericellular space. Collagen molecules (bars) assemble into
quarter-staggered arrays forming fibril intermediates, seen
here as striated structures with tapered ends in longitudinal
section and in cross section as circular profiles. Growth in
length and diameter is by accretion of collagen at this stage.
(b) Fibril intermediates z65 nm in mouse tendons are stabi-
lized, presumably through their interactions with fibril-asso-
ciated macromolecules. (c) The fibril intermediates are the
basic units used in the growth of fibrils. Fusion of the fibril
intermediates generates the mature fibril in a multistep
manner. Progression through this growth process could be
both by additive fusion (i.e., the 64-nm diameter intermedi-
ate adds to its product, indicated by horizontal arrows) and
by like-fusion (i.e., products from different steps can only
fuse with like products, indicated by arrows in the oblique
direction). (d, top) The proportion of the assembly and
growth steps occurring during development is illustrated.
At early stages, assembly is the main event and its propor-
tion gradually decreases to the minimum degree necessary
for maintenance at maturation. The proportion of progressional growth increases gradually to z1 mo and decreases to maturation. (bot-
tom) The expression data for lumican and fibromodluin is illustrated. The phenotypes observed in mutant mice indicate stage-specific reg-
ulatory mechanisms. At 4 d, both lumican and fibromodulin limit the assembly of the collagen monomers (bars). Characteristic of 10 d, pro-
gressional growth begins, and changes in both lumican and fibromodulin promote the transition from assembly to fibril growth by fusion
(thin arrows). At later stages, only fibromodulin promotes the progressional growth steps (thick arrows).Ezura et al. Lumican and Fibromodulin Regulate Fibril Formation 787
increases significantly. In addition, lumican and fibromod-
ulin compete for the same binding sites on the fibril and fi-
bromodulin has the higher affinity (Svensson et al., 2000).
This suggests that the transitions in growth could be medi-
ated by the fibromodulin-displacing lumican from the
fibril surface during a period critical for intermediate fu-
sion. Our data also indicate that fibromodulin facilitates
the formation of the mature, large-diameter fibrils seen at
3-mo postnatal.
Our data demonstrate that lumican and fibromodulin
have differential expression patterns during normal ten-
don development. The studies of the lumican-, fibromodu-
lin-, and double-deficient mice indicate that these two
leucine-rich repeat proteins/proteoglycans have different
developmental stage-specific functions in the regulation of
fibrillogenesis. We propose that these developmental
stage-specific functions are mediated by the differential
expression patterns of lumican and fibromodulin.
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